News Focus
News Focus
icon url

kund

02/06/25 6:20 PM

#482624 RE: Hoskuld #482622

That seems like plenty of incentive to stop development of marginal therapies.

The same principle applies to Anavex; hence, no new trial has been started. I guess PD, Rett, and Fragile X are all shelved.





.